As of August 28, 2026, BlackRock Health Sciences Trust (BME) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. BlackRock Health Sciences Trust has a market capitalization of $519.94M, 12.92M shares outstanding, 76 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BME.
Market Data
Market Cap$519.94M
Shares Outstanding12.92M
FloatN/A
Cash$548
Debt$894.3K
Short InterestN/A
Institutional Holdings
QoQ: ↓ 53.2% shares (2026Q1 vs prior)
76 institutional holders · 3.32M shares
#1
MORGAN STANLEY
1.03M shares
#2
BANK OF AMERICA CORP /DE/
266.5K shares
#3
1607 Capital Partners, LLC
233.3K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest37.0K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track BME Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BME — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
More Research for BME
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.